Skip to main content

Pelvic Pain

1
Pipeline Programs
5
Companies
7
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
RelugolixPhase 23 trials
Active Trials
NCT06462014Completed507Est. Dec 2024
NCT06279195Withdrawn0Est. Nov 2025
NCT05765500Recruiting110Est. Jan 2028
Revalesio
RevalesioWA - Tacoma
1 program
Electro-kinetically Modified WaterN/A1 trial
Active Trials
NCT02523794Terminated9Est. Sep 2016
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Home Pelvic Floor TrainerN/A1 trial
Active Trials
NCT06909539Not Yet Recruiting150Est. Jan 2027
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
My Pelvic PlanN/A1 trial
Active Trials
NCT07066345Completed49Est. Jan 2026
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
ObservationN/A1 trial
Active Trials
NCT03786588Unknown1Est. Dec 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
PfizerRelugolix
PfizerRelugolix
Human BioSciencesMy Pelvic Plan
Colorado TherapeuticsHome Pelvic Floor Trainer
PfizerRelugolix
UNION therapeuticsObservation
RevalesioElectro-kinetically Modified Water

Clinical Trials (7)

Total enrollment: 826 patients across 7 trials

Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment

Start: Jun 2024Est. completion: Nov 20250
Phase 2Withdrawn

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

Start: Feb 2024Est. completion: Jan 2028110 patients
Phase 2Recruiting

Comparing Integrative Interventions for Chronic Pelvic Pain

Start: Aug 2025Est. completion: Jan 202649 patients
N/ACompleted
NCT06909539Colorado TherapeuticsHome Pelvic Floor Trainer

HOme PElvic Floor Improvement Trainer Trial

Start: Jun 2025Est. completion: Jan 2027150 patients
N/ANot Yet Recruiting

Description of Relugolix Use in Patients With Prostate Cancer Within the VHA

Start: Jun 2024Est. completion: Dec 2024507 patients
N/ACompleted

Patients With Chronic Pelvic Pain With Vaginal Microbiota

Start: Dec 2018Est. completion: Dec 20201 patients
N/AUnknown
NCT02523794RevalesioElectro-kinetically Modified Water

Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis

Start: Aug 2015Est. completion: Sep 20169 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 826 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.